$MDRX News
Last published 1y ago
- 1y agoLUCDPAVMABCMDRXLucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of DirectorsPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
- 1y agoMDRXAllscripts Software, LLC - Appeal, AffirmedUS Patent Trial and Appeal Board
- 2y agoMDRXALLSCRIPTS SOFTWARE, LLC - Appeal, ReversedUS Patent Trial and Appeal Board
- 2y agoMDRXRobbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to ShareholdersBusiness WireShareholder rights law firm Robbins LLP is investigating Veradigm Inc. (NASDAQ:MDRX) to determine whether certain Veradigm officers and directors violated securities laws and breached fiduciary duties to shareholders in
- 2y agoMDRXALLSCRIPTS SOFTWARE, LLC - Appeal, AffirmedUS Patent Trial and Appeal Board
- 2y agoMDRXAllscripts Software, LLC - Appeal, AffirmedUS Patent Trial and Appeal Board
- 2y agoMDRXVeradigm to Participate in TD Cowen Annual Health Care ConferenceBusiness WireVeradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho, Veradigm interim Chief Executive Officer, and Lee Westerfield, interim Chief
- 2y agoMDRXVeradigm Receives Expected Delisting Notice from NasdaqBusiness WireContinues to Work Diligently Towards Regaining Compliance Veradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a
- 2y agoMDRXVeradigm Provides Update on its Financial Restatement ProcessBusiness WireExpects Not to File Required Financial Statements by Nasdaq's February 27, 2024 Deadline Working Diligently to File Required Financial Statements and Restore Listing Adopts Limited Duration Stockholder Rights
- 2y agoMDRXVeradigm to Acquire ScienceIOBusiness WireVeradigm to Leverage ScienceIO's Leading Healthcare Artificial Intelligence (AI) Platform on the Company's Large-Scale, High-Quality Data Set to Build Advanced, Private Language Models for Healthcare Expected to
- 2y agoMDRXVeradigm to Highlight New EHR-Integrated Care Gap Alert Solution at ViVE 2024 ConferenceBusiness WireRecently debuted Veradigm Payer Insights is delivering care cap alerts to thousands of providers and growing fast as demand for payer-provider interoperability continues to increase Veradigm Inc. (NASDAQ:MDRX), a
- 2y agoMDRXVeradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.Business WireUsing de-identified data for 53 million unique cardiovascular patients, the report examines prevalence across all 50 states and a variety of demographics Which region of the U.S. has the highest rates of hypertension,
- 2y agoMDRXVeradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular HealthBusiness WireVeradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of Cardiology (ACC)-sponsored initiative aimed at improving
- 2y agoMDRXVERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their OptionsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Veradigm Inc. ("Veradigm" or the "Company")...
- 2y agoMDRXVERADIGM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their OptionsGlobeNewswireIf you suffered losses exceeding $100,000 investing in Veradigm securities between February 26, 2021 and June 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly
- 2y agoMDRXOMCLSKYAUCDKOmnicell Elects Eileen Voynick to Board of DirectorsBusiness WireSales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy
- 2y agoMDRXVERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their OptionsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Veradigm Inc. ("Veradigm" or the "Company")...
- 2y agoMDRXVERADIGM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their OptionsGlobeNewswireIf you suffered losses exceeding $100,000 investing in Veradigm securities between February 26, 2021 and December 7, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly
- 2y agoMDRXNew Veradigm Leadership Provides Outlook on Business and Strategy, and Refreshed Financial Estimates for Fiscal 2023Business WireThe new leadership team at Veradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology solutions, has provided refreshed estimated, unaudited ranges of financial information for fiscal 2023. Dr.
- 2y agoMDRXVeradigm Selects MedAllies as its Qualified Health Information Network™ (QHIN™ ) PartnerPR NewswireMedAllies, a leading healthcare interoperability and connectivity services provider, announced today that Veradigm Inc. (NASDAQ: MDRX), a leading...
- 2y agoMDRXBerman Tabacco Announces Investigation of Veradigm Inc. (MDRX) for Potential Securities Law ViolationsGlobeNewswireBOSTON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ:MDRX).
- 2y agoMDRXVeradigm Leadership Team to Present at J.P. Morgan Healthcare ConferenceBusiness WireVeradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology solutions, announced today that Dr. Shih-Yin Ho, Veradigm interim Chief Executive Officer and board member, and Lee Westerfield, interim
- 2y agoMDRXVERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their OptionsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Veradigm Inc. ("Veradigm" or the "Company")...
- 2y agoMDRXVeradigm Strengthens Award-Winning Revenue Cycle Services Portfolio with Acquisition of Full-Service RCM CompanyBusiness WireVeradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology solutions announced today the acquisition of Koha Health, a full-service revenue cycle management (RCM) company. With this acquisition,
- 2y agoMDRXVERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their OptionsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Veradigm Inc. ("Veradigm" or the "Company")...
- 2y agoMDRXVERADIGM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their OptionsGlobeNewswireIf you suffered losses exceeding $100,000 investing in Veradigm securities between February 26, 2021 and June 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at
- 2y agoMDRXVERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their OptionsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Veradigm Inc. ("Veradigm" or the "Company")...
- 2y agoMDRXVeradigm Inc. Announces that Nasdaq Hearings Panel has Granted its Continued Listing, Pending Return to Compliance with Nasdaq Filing RequirementsBusiness WireVeradigm Inc. (NASDAQ: MDRX (the "Company")) announced today that it received a decision from the Nasdaq Hearings Panel (the "Panel") granting its request for continued listing on the Nasdaq Capital Market, subject to
- 2y agoMDRXVeradigm to Enhance Independent Practice Financial Management with AI for Practice Fusion Billing ServicesBusiness WireVeradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology solutions, announced today that it will now offer a conversational artificial intelligence (AI) agent for Practice Fusion Billing
- 2y agoMDRXVERADIGM SHAREHOLDER UPDATE: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of Upcoming DeadlineGlobeNewswireNEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds shareholders that a complaint has been filed on behalf of purchasers of the common stock of Veradigm Inc ("Veradigm" or the "Company")
- 2y agoMDRXVeradigm Inc. Announces Leadership TransitionBusiness WireGreg Garrison Named Executive Chairman; Dr. Shih-Yin Ho Appointed Interim CEO; Lee Westerfield Appointed Interim CFO Veradigm Inc. (NASDAQ:MDRX) announced today that the Company's Board of Directors appointed
- 2y agoMDRXVERADIGM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their OptionsGlobeNewswireIf you suffered losses exceeding $100,000 investing in Veradigm securities between February 26, 2021 and June 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at
- 2y agoMDRXVERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Veradigm To Contact Him Directly To Discuss Their OptionsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Veradigm Inc. ("Veradigm" or the "Company")...
- 2y agoMDRXVeradigm Inc. Reminder: Robbins LLP is Investigating MDRX on Behalf of InvestorsBusiness WireShareholder rights law firm Robbins LLP is investigating Veradigm Inc. (NASDAQ:MDRX) to determine whether certain Veradigm officers and directors violated securities laws and breached fiduciary duties to shareholders.
- 2y agoMDRXVeradigm Inc. Investors Should Contact Robbins LLP for Information About Our Investigation of MDRXGlobeNewswireSAN DIEGO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Veradigm Inc. (NASDAQ:MDRX) to determine whether certain Veradigm officers and directors violated securities laws
- 2y agoMDRXVeradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-QBusiness WireVeradigm Inc. (NASDAQ:MDRX) announced today that, as expected, it received a notice from Nasdaq indicating that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) because the Company has not filed its
- 3y agoMDRXVeradigm to Simplify Patient Payment Journey with Veradigm Intelligent PaymentsBusiness WireNew solution to help providers digitally engage with patients, improving both practice efficiency and the patient experience Veradigm, Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology solutions
- 3y agoMDRXVeradigm Inc. Announces Receipt of Nasdaq Stay ExtensionBusiness WireVeradigm Inc. (NASDAQ:MDRX) announced today that, on October 6, 2023, it received a notice from Nasdaq indicating that the temporary stay of delisting of the Company's common stock has been extended pending a hearing
- 3y agoMDRXVeradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost TransparencyPR NewswireNew chapter in pharmacy connectivity, expansion of the Veradigm Network and FDB Vela ePrescribing Network introduced SOUTH SAN FRANCISCO and CHICAGO, Oct. 6, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), a major
- 3y agoMDRXAllscripts Software, LLC - Appeal, AffirmedUS Patent Trial and Appeal Board
- 3y agoMDRXHolmusk, Veradigm Announce New Phase of Strategic Investment to Fuel Innovation and Close the Evidence Gap in Behavioral HealthBusiness WireExpanded database will enable deeper analysis and insights to enhance care delivery and improve behavioral health outcomes Veradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology solutions,
- 3y agoMDRXVeradigm and On Belay Health Solutions Collaborate to Expand Value-Based Care Solutions to More Primary Care PracticesBusiness WireVeradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology solutions and On Belay Health Solutions, the company on a mission to empower primary care practices to succeed in value-based care,
- 3y agoMDRXVeradigm Inc. Announces Receipt of Nasdaq Delisting Notice and Intent to AppealBusiness WireVeradigm Inc. (NASDAQ:MDRX) announced today that, on September 20, 2023 and as anticipated in its September 18 release, it received a notice from Nasdaq indicating that the Company's shares would be delisted due to
- 3y agoMDRXVeradigm Inc. Provides Audit Update and Updates Financial Guidance for 2023Business WireVeradigm Inc. (NASDAQ:MDRX) announced today that the work effort to conclude on its previously disclosed accounting and internal control errors has taken longer than previously expected, and more time is needed to
- 3y agoMDRXMelissa Supports Healthcare Practice Management Providers with Project US@ Data ComplianceGlobeNewswireRANCHO SANTA MARGARITA, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Melissa, a leading provider of global data quality, identity verification, and address management solutions, today announced its support of healthcare
- 3y agoMDRXVeradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q FilingBusiness WireVeradigm Inc. (NASDAQ:MDRX) announced today that, as expected, it received a notice from Nasdaq indicating that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) because the Company has not filed its
- 3y agoMDRXMDRX NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Veradigm Inc.GlobeNewswireNEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that it is investigating allegations that Veradigm Inc. ("Veradigm") (NASDAQ:MDRX) violated federal securities laws. CURRENT
- 3y agoMDRXMDRX NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Veradigm Inc.PR NewswireNEW YORK, Aug. 1, 2023 /PRNewswire/ -- The Klein Law Firm announces that it is investigating allegations that Veradigm Inc. ("Veradigm") (NASDAQ:MDRX) violated federal securities laws. CURRENT INVESTIGATION
- 3y agoMDRXMDRX ALERT: The Law Offices of Vincent Wong Investigate Veradigm Inc. for Potential Violations of Securities LawsPR NewswireNEW YORK, July 31, 2023 /PRNewswire/ -- Attention Veradigm Inc. ("Veradigm") (NASDAQ:MDRX) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into Veradigm and certain of
- 3y agoMDRXMDRX FRAUD ALERT: Jakubowitz Law is Investigating Veradigm Inc. in Connection with Potential Violations of Federal Securities LawsPR NewswireNEW YORK, July 28, 2023 /PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Veradigm Inc. (NASDAQ:MDRX) To be contacted by